BioSpace News Archive

Rising prevalence of neglected tropical diseases and increasing adoption of modern diagnostic services are key factors fueling global market growth.

Parent Project Muscular Dystrophy (PPMD), a US nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), and Jesse’s Journey, Canada’s leading charity fighting to defeat Duchenne, today announced a collaborative research award of $172,000 (CAD) in support of a two-year Clinical Fellowship in Duchenne Endocrinology and Bone Fragility.

PierianDx, the global leader in clinical genomics knowledge, today announced that it will work with existing partner, Intermountain Healthcare, to support Myriad Genetics’ comprehensive germline and somatic tumor testing service

Cure Network Dolby Acceleration Partners LLC and Takeda Pharmaceutical Company Limited have entered into a research collaboration to develop small molecules targeting tau, a protein involved in Alzheimer’s disease and other major brain disorders.

The American Diabetes Association® issued important updates to the 2021 Standards of Medical Care in Diabetes, in annotations as the Living Standards of Care.

Increasing breast cancer cases around the globe and growing need for early detection of breast cancer are some key factors supporting market revenue growth.

Rising geriatric population and increasing incidences of age-related disorders are key factors expected to drive market growth.

Advancements in DNA microarray techniques, growing prevalence of various diseases, and increasing need for rapid and accurate diagnosis are key factors fueling global market growth

Crinetics Pharmaceuticals, Inc. today announced the appointment of Garlan Adams to the newly created role of general counsel.

ReViral Ltd.today announced the successful completion of Part A of the phase 2 clinical study of sisunatovir for the treatment of RSV infections in hospitalized infants (REVIRAL1). REVIRAL1 is a global three-part adapti